Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins
Preprint
Abstract
Summary: Glioblastoma (GBM) treatment includes maximal safe resection of the core and MRI contrast-enhancing (CE) tumor. Complete resection of the infiltrative non-contrast-enhancing (NCE) tumor rim is rarely achieved. We established a safe, semi-automated workflow for spatially-registered sampling of MRI-defined GBM regions in 19 patients with downstream analysis and biobanking, enabling studies of NCE, wherefrom recurrence/progression typically occurs. Immunophenotyping revealed underrepresentation of myeloid cell subsets and CD8+ T cells in the NCE. While NCE T cells phenotypically and functionally resembled those in matching CE tumor, subsets of activated (CD69 hi ) effector memory CD8+ T cells were overrepresented. Contrarily, CD25 hi Tregs and other subsets were underrepresented. Overall, our study demonstrated that MRI-guided, spatially-registered, intraoperative immunosampling is feasible as part of routine GBM surgery. Further elucidation of the shared and spatially distinct microenvironmental biology of GBM will enable development of therapeutic approaches targeting the NCE infiltrative tumor to decrease GBM recurrence.Keywords
This publication has 11 references indexed in Scilit:
- Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastomaCancer Cell, 2022
- Glioma targeted therapy: insight into future of molecular approachesMolecular Cancer, 2022
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018Neuro-Oncology, 2021
- Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center studyScientific Reports, 2021
- MRI and PET of Brain Tumor Neuroinflammation in the Era of Immunotherapy, From the AJR Special Series on InflammationAmerican Journal of Roentgenology, 2021
- Role of PAI-1 in hepatic steatosis and dyslipidemiaScientific Reports, 2021
- Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery CommitteeJournal for ImmunoTherapy of Cancer, 2020
- Immune suppression in gliomasJournal of Neuro-Oncology, 2020
- Adult GlioblastomaJournal of Clinical Oncology, 2017
- A comprehensive profile of recurrent glioblastomaOncogene, 2016